CD44 and neoplasm: HCC CSC Study. A study of tumor heterogeneity and stemness-associated HCC subgroups in hepatocellular carcinoma. A rare CD24+CD44+ subpopulation of HCC with specific oncogenic features was identified in EPCAM+ tumor cells